Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Teddy3on Sep 26, 2021 7:04am
205 Views
Post# 33920393

No Aristotle testing in Q3? What a joke. (R.I.P)

No Aristotle testing in Q3? What a joke. (R.I.P)I refuse to listent to the likely very dull presentation but you are saying there is not likely Aristotle testing in Q3? WOW. I wonder if anyone wants to ask Rebecca what the Q1 launch was for? Tripp and Rebecca are a great team of misleaders who feed on retail traders for years. They need to ensure their oversized paychecks keep coming in.

Lith, Jonny, Cape, Mykndrson, Photobaby and the rest of the employee's LOVE IT! They just can't get enough. They are all waiting to hear the next things Tripp and her say to believe with all their hearts! They are a very smart bunch everyone should listen to the employee gang and Tripp/Rebecca since they are always correct so intelligent. Look how well SZLS is doing!

When Q4 Aristotle release turns into 2022 Q1 release dont be shocked...

User image
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse